An annual research and development day hosted by Cambridge biotech company Moderna revealed several advancements in mRNA vaccine technology, including a combination coronavirus and flu booster that’s in the works.
An annual research and development day hosted by Cambridge biotech company Moderna revealed several advancements in mRNA vaccine technology, including a combination coronavirus and flu booster that’s in the works. “We believe our mRNA platform can solve the world’s greatest health challenges, from diseases impacting millions, to ultra-rare diseases impacting dozens, to medicines personalized down to the individual level,” said Stephane Bancel, CEO of Moderna. Bancel on Thursday announced the development of a single-dose vaccine that combines a booster against the coronavirus and a booster against the flu. The combo vaccine encodes for COVID’s spike protein and influenza’s proteins as well.
